```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2568 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 2568

To direct the Secretary of Veterans Affairs to study and report on the 
 prevalence of cholangiocarcinoma in veterans of the Vietnam era, and 
                          for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 7, 2019

 Mr. Zeldin (for himself, Mr. Fitzpatrick, Mr. Suozzi, Mr. Thompson of 
   California, Mr. King of New York, Miss Rice of New York, and Ms. 
   Lofgren) introduced the following bill; which was referred to the 
                     Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
To direct the Secretary of Veterans Affairs to study and report on the 
 prevalence of cholangiocarcinoma in veterans of the Vietnam era, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Vietnam Veterans Liver Fluke Cancer 
Study Act''.

SEC. 2. STUDY ON THE PREVALENCE OF CHOLANGIOCARCINOMA IN VETERANS OF 
              THE VIETNAM ERA.

    (a) Epidemiological Study.--Not later than 120 days after the date 
of enactment of this Act, the Secretary of Veterans Affairs, in 
consultation with the Director of the Centers for Disease Control and 
Prevention of the Department of Health and Human Services, shall 
commence an epidemiological study on the prevalence of 
cholangiocarcinoma in veterans of the Vietnam era, using data from the 
Veterans Affairs Central Cancer Registry and the National Program of 
Cancer Registries. The study shall--
            (1) identify the rate of incidence of cholangiocarcinoma in 
        veterans of the Vietnam era and in residents of the United 
        States, from the beginning of the Vietnam era to the date of 
        enactment of this Act; and
            (2) for each of the groups specified in paragraph (1), 
        identify the percentage of individuals with cholangiocarcinoma 
        by various demographic characteristics, including by age, 
        gender, race, ethnicity, and the geographic location of the 
        patient at the time of diagnosis.
    (b) Report to Congress.--Not later than one year after the 
completion of the study under subsection (a), the Secretary shall 
submit to Congress a report containing--
            (1) the results of the study under subsection (a); and
            (2) recommendations for administrative or legislative 
        actions required to address issues identified in the study 
        under subsection (a).
    (c) Continued Tracking of Cholangiocarcinoma in Veterans of the 
Vietnam Era.--The Secretary shall track the prevalence of 
cholangiocarcinoma in veterans of the Vietnam era using the Veterans 
Affairs Central Cancer Registry, and provide such information to 
Congress as required under subsection (d).
    (d) Follow-Up Reports.--The Secretary shall periodically submit to 
the Congress an updated report under subsection (b), as determined by 
the Secretary.
    (e) Definitions.--In this section:
            (1) The term ``Secretary'' means the Secretary of Veterans 
        Affairs.
            (2) The term ``Vietnam era'' has the meaning given such 
        term in section 101 of title 38, United States Code.
            (3) The term ``veterans of the Vietnam era'' has the 
        meaning given such term in section 4211 of title 38, United 
        States Code.
                                 <all>
```